Point-of-Care Testing of Hemostasis in Cardiac Surgery
AUTOR(ES)
Prisco, Domenico
FONTE
BioMed Central
RESUMO
An excessive perioperative blood loss, that requires transfusion of blood products, sometimes occurs in patients undergoing cardiopulmonary bypass for cardiac surgery. Blood loss and transfusion requirements in these patients may be reduced with a better control of heparin treatment and its reversal. Blood component administration in patients with excessive post-cardiopulmonary bypass bleeding has been empiric for a long time due to turnaround times of laboratory coagulation tests. Devices are now available for rapid, point-of-care assessment of hemostasis alterations to allow an appropriate, targeted therapy. In particular, a quick evaluation of platelet and coagulation defects with new point-of-care devices can optimize the administration of pharmacological and transfusion-based therapy in patients with excessive bleeding after cardiopulmonary bypass.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=166118Documentos Relacionados
- Usefulness of Point-of-Care Testing in the Treatment of Diabetes in an Underserved Population
- Cardiac point-of-care ultrasound curriculum for anesthesia residents: the time is now
- RNI Point-of-care test (POCT): esperança ou ilusão?
- Acceptability of perinatal rapid point‐of‐care HIV testing in an area of low HIV prevalence in the UK
- Smartphone for Point-of-Care Quantification of Protein by Bradford Assay
